Mitsubishi UFJ Trust & Banking’s ANI Pharmaceuticals ANIP Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$466K	Buy	+5,629	New	+$452K	﹤0.01%	1082

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's ANIP Position: Q2 2026 in Review

Mitsubishi UFJ Trust & Banking opened a new position in ANI Pharmaceuticals (ANIP) in Q2 2026: 5,629 shares worth $466K. The stake represents ﹤0.01% of the portfolio and ranks #1082 among its holdings.

307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

Mitsubishi UFJ Trust & Banking held 5,629 shares of ANI Pharmaceuticals worth $466K as of Q2 2026.
ANI Pharmaceuticals was a new Mitsubishi UFJ Trust & Banking position in Q2 2026.
ANI Pharmaceuticals made up ﹤0.01% of Mitsubishi UFJ Trust & Banking's portfolio in Q2 2026, its #1082 holding.
307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2026, filed 6 Aug 2026.